3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
20
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Diseases
1
Transitional Cell Carcinoma of the Bladder
1
Non-metastatic Muscle Invasive Bladder Cancer
1
Infiltrating Bladder Urothelial Carcinoma
1
Cone Dystrophy 3
1
Carcinoma, Transitional Cell
1
Bladder Adenocarcinoma
1
Interventions
avelumab
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Non-metastatic Muscle Invasive Bladder Cancer
×
Cystectomy
×
Clear all
NCT03674424
2025-02-26
AURA
Jules Bordet Institute
Phase 2
Completed
137 enrolled